E-LIB Suche - Ergebnisse für: Kadri, Sabah

1

P591: Assessing the performance of automated HPO term extra..:

Lee Yap, Kai ; Wong, Anthony ; Tuteja, Sachleen...
Genetics in Medicine Open. 1 (2023) 1 - p. 100638 , 2023

2

Recommendations for the Use of in Silico Approaches for Nex..:

Duncavage, Eric J. ; Coleman, Joshua F. ; de Baca, Monica E....
The Journal of Molecular Diagnostics. 25 (2023) 1 - p. 3-16 , 2023

Link: https://doi.org/10.1016/..

3

A performance evaluation study: Variant annotation tools - ..:

Tuteja, Sachleen ; Kadri, Sabah ; Yap, Kai Lee
Journal of Pathology Informatics. 13 (2022) - p. 100130 , 2022

Link: https://doi.org/10.1016/..

4

Unified classification of mouse retinal ganglion cells usin..:

Goetz, Jillian ; Jessen, Zachary F. ; Jacobi, Anne...
Cell Reports. 40 (2022) 2 - p. 111040 , 2022

Link: https://doi.org/10.1016/..

5

The RNA structurome in the asexual blood stages of malaria ..:

Alvarez, Diana Renteria ; Ospina, Alejandra ; Barwell, Tiffany...
RNA Biology. 18 (2021) 12 - p. 2480-2497 , 2021

Link: https://doi.org/10.1080/..

6

24. Clinical considerations for migration between genome as..:

Kadri, Sabah ; Skol, Andrew
Cancer Genetics. 244 (2020) - p. 9 , 2020

Link: https://doi.org/10.1016/..

7

Building Infrastructure and Workflows for Clinical Bioinfor..:

Kadri, Sabah
Advances in Molecular Pathology. 3 (2020) - p. 157-167 , 2020

Link: https://doi.org/10.1016/..

8

Next-generation sequencing identifies 2 genomically distinc..:

Setia, Namrata ; Wanjari, Pankhuri ; Yassan, Lindsay...
Human Pathology. 97 (2020) - p. 103-111 , 2020

Link: https://doi.org/10.1016/..

9

A phase 1 study of azacitidine with high-dose cytarabine an..:

Odenike, Olatoyosi ; Stock, Wendy ; Larson, Richard A....
Blood Advances. 4 (2020) 4 - p. 599-606 , 2020

Link: https://doi.org/10.1182/..

10

Quantitative next-generation sequencing-based analysis indi..:

Chapel, David B. ; Patil, Sushant A. ; Plagov, Andrei...
Modern Pathology. 32 (2019) 10 - p. 1508-1520 , 2019

Link: https://doi.org/10.1038/..

11

Fewer actionable mutations but higher tumor mutational burd..:

Choudhury, Noura J. ; Eghtesad, Mansooreh ; Kadri, Sabah...
Oncotarget. 10 (2019) 56 - p. 5817-5823 , 2019

Link: https://doi.org/10.18632..

12

Clinical Validation and Implementation of a Measurable Resi..:

Ritterhouse, Lauren L. ; Parilla, Megan ; Zhen, Chao Jie...
Molecular Diagnosis & Therapy. 23 (2019) 6 - p. 791-802 , 2019

Link: https://doi.org/10.1007/..

13

Integrating a Large Next-Generation Sequencing Panel into t..:

Parilla, Megan ; Kadri, Sabah ; Patil, Sushant A...
Journal of Neuropathology & Experimental Neurology. 78 (2019) 3 - p. 257-267 , 2019

Link: https://doi.org/10.1093/..

14

Measurable residual disease monitoring for patients with ac..:

Balagopal, Vidya ; Hantel, Andrew ; Kadri, Sabah...
PLOS ONE. 14 (2019) 10 - p. e0224097 , 2019

Link: https://doi.org/10.1371/..

15

Targeted mutational analysis of inflammatory bowel disease–..:

Alpert, Lindsay ; Yassan, Lindsay ; Poon, Rachel...
Human Pathology. 89 (2019) - p. 44-50 , 2019

Link: https://doi.org/10.1016/..